Shackelford McKinley & Norton’s Raymond L. Panneton Talks Biotech Partnerships in Medical IP Litigation in Bloomberg Law

Bloomberg Law interviewed Shackelford McKinley & Norton partner Raymond L. Panneton about the niche that biotech companies fill in defending medical patents from infringement from foreign rivals.  

Biotech companies can change the context of court from medical technology to private business, removing the concern that protecting patents could harm the public. These companies can also provide resources hospitals and universities may not have on hand for trial.  

“They got more money than God, so they’re willing to throw that at litigation,” Mr. Panneton said. 

Read the full article, with more from Mr. Panneton, here. 

Are you ready to get started?

1-800-559-4534